SanBio is focused on therapies for neurological disorders such as stroke, spinal cord injury, Parkinson's disease and multiple sclerosis.

SanBio is a scientific leader in cell therapies for regenerative medicine. SanBio's products have achieved extraordinary results in animal models of a number of important disorders and having received FDA Investigational New Drug approval, have initiated a Phase I/IIa clinical trial for stroke disability. Read more...